Arkolith/Insider Trading/AQST/Form 4

Jung Cassie

Chief Operating OfficerAquestive Therapeutics, Inc. (AQST) · full profile →Form 4 · filed Mar 11, 2026
Net Selling
Open-Market Buys
$0
Open-Market Sells
$191K
Net Open-Market Flow
-$191K
Transactions
3
2 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Mar 10, 2026Sell(S)46K$4.17$191K275K
Mar 9, 2026Grant(A)80K—$0321K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Mar 9, 2026Grant(A)43K—$043K

Transaction Codes

S
Open-market sale
A
Grant / award

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001214659-26-003141) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML